S
Susanne Bonekamp
Researcher at Heidelberg University
Publications - 48
Citations - 4395
Susanne Bonekamp is an academic researcher from Heidelberg University. The author has contributed to research in topics: Population & Magnetic resonance imaging. The author has an hindex of 27, co-authored 48 publications receiving 3728 citations. Previous affiliations of Susanne Bonekamp include Johns Hopkins University & Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis
Ruben Hernaez,Ruben Hernaez,Mariana Lazo,Susanne Bonekamp,Ihab R. Kamel,Frederick L. Brancati,Eliseo Guallar,Jeanne M. Clark +7 more
TL;DR: Ultrasonography allows for reliable and accurate detection of moderate‐severe fatty liver, compared to histology, and is likely the imaging technique of choice for screening for fatty liver in clinical and population settings.
Journal ArticleDOI
Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994
Mariana Lazo,Ruben Hernaez,Ruben Hernaez,Mark S. Eberhardt,Susanne Bonekamp,Ihab R. Kamel,Eliseo Guallar,Ayman Koteish,Frederick L. Brancati,Jeanne M. Clark +9 more
TL;DR: The results extend previous national estimates of the prevalence of NAFLD in the US population and highlight the burden of this disease, which is more common in men, Mexican Americans, and people with diabetes and obesity are the most affected groups.
Journal ArticleDOI
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study.
Mariana Lazo,Ruben Hernaez,Susanne Bonekamp,Ihab R. Kamel,Frederick L. Brancati,Eliseo Guallar,Jeanne M. Clark +6 more
TL;DR: Non-alcoholic fatty liver disease was not associated with an increased risk of death from all causes, cardiovascular disease, cancer, or liver disease.
Journal ArticleDOI
Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes
Mariana Lazo,Steven F. Solga,Alena Horská,Susanne Bonekamp,Anna Mae Diehl,Frederick L. Brancati,Lynne E. Wagenknecht,F. Xavier Pi-Sunyer,Steven E. Kahn,Jeanne M. Clark +9 more
TL;DR: A 12-month intensive lifestyle intervention in patients with type 2 diabetes reduces steatosis and incident nonalcoholic fatty liver disease (NAFLD).
Journal ArticleDOI
Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately
TL;DR: Elastographic measurements, either ultrasonography-based or magnetic resonance-based, and magnetic resonance diffusion weighted imaging, show the most promise for accurate staging of hepatic fibrosis and Utrasonographic elastography and magnetic Resonance diffusion weighted appear next most promising.